QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (79) Citing Articles via Google Scholar Google Scholar Articles by Zhang, F. Articles by Iadecola, C. Search for Related Content PubMed PubMed Citation Articles by Zhang, F. Articles by Iadecola, C.

 Previous Article  |  Next Article 

Volume 17, Number 20, Issue of October 15, 1997 pp. 7655-7661
Copyright ©1997 Society for Neuroscience

Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein

Received June 13, 1997; revised July 22, 1997; accepted Aug. 5, 1997.

Fangyi Zhang¹, Chris Eckman², Steven Younkin², Karen K. Hsiao¹, and Costantino Iadecola¹

¹ Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455, and ² Mayo Clinic Jacksonville, Jacksonville, Florida 32224

We studied the role of the amyloid precursor protein (APP) in ischemic brain damage using transgenic mice overexpressing APP. The middle cerebral artery (MCA) was occluded in FVB/N mice expressing APP₆₉₅.SWE (Swedish mutation) and in nontransgenic littermates. Infarct volume (cubic millimeters) was assessed 24 hr later in thionin-stained brain sections. The infarct produced by MCA occlusion was enlarged in the transgenics (+32 ± 6%; n = 12; p < 0.05; t test). Measurement of APP by ELISA revealed that, although relatively high levels of A were present in the brain of the transgenics (A_1-40 = 80 ± 19 pmol/g; n = 6), there were no differences between ischemic and nonischemic hemispheres (p > 0.05). The reduction in cerebral blood flow produced by MCA occlusion at the periphery of the ischemic territory was more pronounced in APP transgenics (42 ± 8%; n = 9) than in controls (20 ± 8%; n = 9). Furthermore, the vasodilatation produced by neocortical application of the endothelium-dependent vasodilator acetylcholine (10 µM) was reduced by 82 ± 5% (n = 8; p < 0.05) in APP transgenics. The data demonstrate that APP overexpression increases the susceptibility of the brain to ischemic injury. The effect is likely to involve the A-induced disturbance in endothelium-dependent vascular reactivity that leads to more severe ischemia in regions at risk for infarction. The cerebral vascular actions of peptides deriving from APP metabolism may play a role in the pathogenic effects of APP.

Key words: middle cerebral artery; Alzheimer's disease; cerebral ischemia; stroke; cerebral blood flow; transgenic mice

This article has been cited by other articles:

				S. N. Whitehead, G. Cheng, V. C. Hachinski, and D. F. Cechetto Progressive Increase in Infarct Size, Neuroinflammation, and Cognitive Deficits in the Presence of High Levels of Amyloid Stroke, December 1, 2007; 38(12): 3245 - 3250. [Abstract] [Full Text] [PDF]

				H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy Brain, September 1, 2007; 130(9): 2310 - 2319. [Abstract] [Full Text] [PDF]

				J. Paul, S. Strickland, and J. P. Melchor Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease J. Exp. Med., August 6, 2007; 204(8): 1999 - 2008. [Abstract] [Full Text] [PDF]

				H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2-Derived Radicals Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 826 - 832. [Abstract] [Full Text] [PDF]

				J. A. H. R. Claassen and R. W. M. M. Jansen Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis. J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2006; 61(3): 267 - 271. [Abstract] [Full Text] [PDF]

				H. Girouard and C. Iadecola Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease J Appl Physiol, January 1, 2006; 100(1): 328 - 335. [Abstract] [Full Text] [PDF]

				L. Park, J. Anrather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. A. Carlson, and C. Iadecola NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid {beta} Peptide J. Neurosci., February 16, 2005; 25(7): 1769 - 1777. [Abstract] [Full Text] [PDF]

				R. Minkeviciene, P. Banerjee, and H. Tanila Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer's Disease J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 677 - 682. [Abstract] [Full Text] [PDF]

				A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll Temporal Alterations in Cerebrospinal Fluid Amyloid {beta}-Protein and Apolipoprotein E After Subarachnoid Hemorrhage Stroke, December 1, 2003; 34 (12): e240 - e243. [Abstract] [Full Text] [PDF]

				C. Iadecola Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer's Dementia Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1951 - 1953. [Full Text] [PDF]

				M. Koistinaho, M. I. Kettunen, D. M. Holtzman, R. A. Kauppinen, L. S. Higgins, and J. Koistinaho Expression of Human Apolipoprotein E Downregulates Amyloid Precursor Protein-Induced Ischemic Susceptibility Stroke, July 1, 2002; 33(7): 1905 - 1910. [Abstract] [Full Text] [PDF]

				K. Niwa, K. Kazama, L. Younkin, S. G. Younkin, G. A. Carlson, and C. Iadecola Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H315 - H323. [Abstract] [Full Text] [PDF]

				M. Koistinaho, M. I. Kettunen, G. Goldsteins, R. Keinanen, A. Salminen, M. Ort, J. Bures, D. Liu, R. A. Kauppinen, L. S. Higgins, et al. beta -Amyloid precursor protein transgenic mice that harbor diffuse Abeta deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation PNAS, January 24, 2002; (2002) 32670899. [Abstract] [Full Text] [PDF]

				S. M. Fitzjohn, R. A. Morton, F. Kuenzi, T. W. Rosahl, M. Shearman, H. Lewis, D. Smith, D. S. Reynolds, C. H. Davies, G. L. Collingridge, et al. Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein J. Neurosci., July 1, 2001; 21(13): 4691 - 4698. [Abstract] [Full Text] [PDF]

				N. Hosomi, J. Lucero, J. H. Heo, J. A. Koziol, B. R. Copeland, and G. J. del Zoppo Rapid Differential Endogenous Plasminogen Activator Expression After Acute Middle Cerebral Artery Occlusion Stroke, June 1, 2001; 32(6): 1341 - 1348. [Abstract] [Full Text] [PDF]

				A. Majid, Y. Y. He, J. M. Gidday, S. S. Kaplan, E. R. Gonzales, T. S. Park, J. D. Fenstermacher, L. Wei, D. W. Choi, C. Y. Hsu, et al. Differences in Vulnerability to Permanent Focal Cerebral Ischemia Among 3 Common Mouse Strains Editorial Comment Stroke, November 1, 2000; 31(11): 2707 - 2714. [Abstract] [Full Text] [PDF]

				K. Niwa, L. Younkin, C. Ebeling, S. K. Turner, D. Westaway, S. Younkin, K. H. Ashe, G. A. Carlson, and C. Iadecola Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation PNAS, August 15, 2000; 97(17): 9735 - 9740. [Abstract] [Full Text] [PDF]

				K. Niwa, E. Araki, S. G. Morham, M. E. Ross, and C. Iadecola Cyclooxygenase-2 Contributes to Functional Hyperemia in Whisker-Barrel Cortex J. Neurosci., January 15, 2000; 20(2): 763 - 770. [Abstract] [Full Text] [PDF]

				F. M. Faraci and C. D. Sigmund Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight Circ. Res., December 3, 1999; 85(12): 1214 - 1225. [Full Text] [PDF]

				A. LeBlanc, H. Liu, C. Goodyer, C. Bergeron, and J. Hammond Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer's Disease J. Biol. Chem., August 13, 1999; 274(33): 23426 - 23436. [Abstract] [Full Text] [PDF]

				D. H. Smith, M. Nakamura, T. K. McIntosh, J. Wang, A. Rodriguez, X.-H. Chen, R. Raghupathi, K. E. Saatman, J. Clemens, M. L. Schmidt, et al. Brain Trauma Induces Massive Hippocampal Neuron Death Linked to a Surge in ß-Amyloid Levels in Mice Overexpressing Mutant Amyloid Precursor Protein Am. J. Pathol., September 1, 1998; 153(3): 1005 - 1010. [Abstract] [Full Text] [PDF]

				A. R. White, H. Zheng, D. Galatis, F. Maher, L. Hesse, G. Multhaup, K. Beyreuther, C. L. Masters, and R. Cappai Survival of Cultured Neurons from Amyloid Precursor Protein Knock-Out Mice against Alzheimer's Amyloid-beta Toxicity and Oxidative Stress J. Neurosci., August 15, 1998; 18(16): 6207 - 6217. [Abstract] [Full Text] [PDF]

				K.-A. Hossmann Experimental models for the investigation of brain ischemia Cardiovasc Res, July 1, 1998; 39(1): 106 - 120. [Full Text] [PDF]

				G. Yang, R. M. Feddersen, F. Zhang, H. B. Clark, A. J. Beitz, and C. Iadecola Cerebellar vascular and synaptic responses in normal mice and in transgenics with Purkinje cell dysfunction Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R529 - R540. [Abstract] [Full Text] [PDF]

				M. Koistinaho, M. I. Kettunen, G. Goldsteins, R. Keinanen, A. Salminen, M. Ort, J. Bures, D. Liu, R. A. Kauppinen, L. S. Higgins, et al. beta -Amyloid precursor protein transgenic mice that harbor diffuse Abeta deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation PNAS, February 5, 2002; 99(3): 1610 - 1615. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help